Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as an injectable solution for intraarterial, intraarticular and intrathecal use. It provides X‑ray attenuation for radiographic imaging in patients undergoing angiography, arthrography, myelography and other contrast‑enhanced studies.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron, an iodinated contrast agent, is used to enhance radiographic visualization in several imaging procedures. - Angiography: improves delineation of blood vessels for clearer vascular imaging. - Arthrography: outlines joint structures to aid diagnosis of musculoskeletal disorders. - Myelography: highlights the spinal canal and nerve roots for detailed spinal assessment. - General radiographic imaging where contrast enhancement is required: increases radiodensity for better diagnostic interpretation.

Iomeron may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Warmth or flushing sensation at the injection site. - Metallic taste in the mouth. - Nausea or mild vomiting. - Headache or mild dizziness.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Contrast‑induced nephropathy leading to acute kidney injury. - Seizures, hypotension, or cardiac arrhythmias. - Pulmonary edema or respiratory distress. - Persistent skin rash or urticaria.

Before administering Iomeron, clinicians should evaluate patient-specific risk factors and follow appropriate safety measures. - Assess renal function: check serum creatinine or eGFR. - Review history of iodine or contrast media allergy. - Use the lowest effective dose for the intended imaging study. - Monitor vital signs and patient response during and after injection. - Avoid in patients with uncontrolled hyperthyroidism. - Store at or below 25°C: keep in original packaging, protect from light, moisture and freezing.

Iomeron can interact with other medications or conditions that affect renal function or iodine handling.

Major Interactions (Avoid): - Administration of another iodinated contrast agent within 24 hours. - Concurrent use of nephrotoxic drugs (e.g., aminoglycosides, NSAIDs) in patients with impaired kidneys. - Use with metformin in patients with reduced renal function due to risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers may mask contrast‑induced tachycardia. - Diuretics can alter fluid balance and affect contrast distribution. - Thyroid hormone therapy may modify iodine load and require monitoring.